Correlation Between Fortress Biotech and Sangamo Therapeutics
Can any of the company-specific risk be diversified away by investing in both Fortress Biotech and Sangamo Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fortress Biotech and Sangamo Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Fortress Biotech and Sangamo Therapeutics, you can compare the effects of market volatilities on Fortress Biotech and Sangamo Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fortress Biotech with a short position of Sangamo Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fortress Biotech and Sangamo Therapeutics.
Diversification Opportunities for Fortress Biotech and Sangamo Therapeutics
-0.04 | Correlation Coefficient |
Good diversification
The 3 months correlation between Fortress and Sangamo is -0.04. Overlapping area represents the amount of risk that can be diversified away by holding Fortress Biotech and Sangamo Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sangamo Therapeutics and Fortress Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fortress Biotech are associated (or correlated) with Sangamo Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sangamo Therapeutics has no effect on the direction of Fortress Biotech i.e., Fortress Biotech and Sangamo Therapeutics go up and down completely randomly.
Pair Corralation between Fortress Biotech and Sangamo Therapeutics
Given the investment horizon of 90 days Fortress Biotech is expected to under-perform the Sangamo Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Fortress Biotech is 2.11 times less risky than Sangamo Therapeutics. The stock trades about -0.08 of its potential returns per unit of risk. The Sangamo Therapeutics is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest 200.00 in Sangamo Therapeutics on August 30, 2024 and sell it today you would earn a total of 30.00 from holding Sangamo Therapeutics or generate 15.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Fortress Biotech vs. Sangamo Therapeutics
Performance |
| Timeline |
| Fortress Biotech |
| Sangamo Therapeutics |
Fortress Biotech and Sangamo Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Fortress Biotech and Sangamo Therapeutics
The main advantage of trading using opposite Fortress Biotech and Sangamo Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fortress Biotech position performs unexpectedly, Sangamo Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sangamo Therapeutics will offset losses from the drop in Sangamo Therapeutics' long position.| Fortress Biotech vs. Mustang Bio | Fortress Biotech vs. Achilles Therapeutics PLC | Fortress Biotech vs. Aptose Biosciences | Fortress Biotech vs. Fortress Biotech Pref |
| Sangamo Therapeutics vs. Bright Minds Biosciences | Sangamo Therapeutics vs. HP Inc | Sangamo Therapeutics vs. Intel | Sangamo Therapeutics vs. Chevron Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |